RESUMO
Leishmaniasis represents a complex of chronic diseases with a broad geographic distribution and a high significance in public health worldwide. The varied clinical signs in conjunction with the low sensitivity and specificity of canine visceral leishmaniasis (CVL) detection methods make diagnosis of the disease complex. Among the several available laboratory tests, studies have suggested that the detection of parasites in synovial fluid (SF) is a good auxiliary tool in the diagnosis of CVL. However, no study has evaluated the influence of the clinical stage of CVL in the detection of Leishmania sp. in SF. This study aimed to evaluate the detection of Leishmania sp. amastigotes in the SF of dogs at different stages of the disease. The negative control group (G1) comprised 12 dogs that tested negative for CVL. Thirty-six other dogs, tested serologically positive for CVL, were divided into two groups: Group 2 (G2), which included animals at stage II of the disease (moderate; n=18), and Group 3 (G3) included animals at stage III of the disease (severe; n=18). The analysis of SF revealed the presence of parasites in six (33.3%) dogs from G2 and in 16 (88.9%) dogs from G3 (p=0.0437). The present research suggested that SF analysis is of high value as a supplementary tool in the diagnosis of CVL. As a new finding, the present study also indicated that this test has a higher sensitivity in animals presenting with more severe stage of the disease.(AU)
As leishmanioses representam um complexo de doenças de caráter crônico de alta importância na saúde pública mundial e com distribuição geográfica ampla. A apresentação clínica variada e a baixa sensibilidade e especificidade de alguns métodos para a detecção da doença tornam complexo o diagnóstico da leishmainiose visceral canina (LVC). Entre os diversos testes laboratóriais disponíveis, estudos tem sugerido que a pesquisa de parasitos no líquido sinovial (LS) pode ser uma ferramenta auxiliar no diagnóstico da LVC. Apesar disso, inexistem estudos avaliando a relação entre o estágio clínico da doença e a detecção de Leishmania sp. no LS. Dessa forma, o presente trabalho teve como objetivo avaliar a detecção de amastigotas de Leishmania sp. no LS de cães acometidos por diferentes estádios da doença. Foram avaliados 48 cães, sendo 12 negativos para LVC (grupo controle negativo, G1) e 36 soropositivos. O grupo 2 (doença moderada, G2) incluiu animais classificados no estádio II da doença, enquanto o grupo 3 (doença grave, G3) abrangeu animais classificados em estádio III. Na análise do líquido sinovial dos cães, o parasito foi visualizado em seis (33,3%) cães do G2 e 16 (88,9)% dos cães de G3 (p=0.0437). O presente trabalho sugere que a análise do LS apresenta alto valor como ferramenta suplementar no diagnóstico da LVC. Em adição, o presente estudo indica, pela primeira vez, que o teste apresenta uma sensibilidade maior em animais que apresentam a forma grave da doença.(AU)
Assuntos
Animais , Cães , Líquido Sinovial/virologia , Leishmaniose Visceral/diagnóstico , Leishmaniose Visceral/veterinária , Leishmania infantumRESUMO
Viral agents have been suspected as participants of immune-mediated disorders. In the case of rheumatic diseases, the synovial joint cavity represents a secluded area of inflammation which could harbor etiological agents. We analyzed by polymerase chain reaction the possible presence of DNA from various herpes viruses in blood and synovial fluid from patients with either rheumatoid arthritis (n = 18), axial spondyloarthritis (n = 11), or osteoarthritis (n = 8). Relevant findings were as follows: DNA from varicella zoster virus was found in synovial fluid but not in blood mononuclear cells from 33 % of patients with rheumatoid arthritis and in 45 % of patients with axial spondyloarthritis but not in patients with osteoarthritis. Also, DNA from herpes simplex viruses 1 and 2 was found both in the blood and in the synovial fluid from 33 % of patients with rheumatoid arthritis. Our results indicate the occasional presence of DNA from herpes viruses in patients with rheumatoid arthritis or with axial spondyloarthritis. However, these findings might represent a parallel epiphenomenon of viral activation associated either with immunosuppressive therapy or with primary immune disturbances, rather than the etiological participation of herpes viruses in these disorders.